Please login to the form below

Not currently logged in
Email:
Password:

Sanofi exits Zynquista alliance with Lexicon

Sanofi receptionWill pay $260m to end collaboration

Mallinckrodt offloads CDMO for $250m

MallinckrodtMove follows US opioid settlement

Sumitomo Dainippon goes big on biotech with $3bn Roivant deal

Roivant 2Could acquire up to 11 Roivant spinouts

Boehringer bolsters KRAS push with $720m Lupin deal

Signs of progress in the field are emerging

Vertex eyes type 1 diabetes cure with biotech acquisition

Vertex PharmaWill acquire Semma Therapeutics for $950m

'Therapeutic overcrowding' could hit big pharma returns

Jefferies analysts identify most at-risk companies

FDA clears Lilly’s Taltz for ankylosing spondylitis

TaltzNew indication boosts $1bn+ hopes for this year

Pfizer goes big on gene therapy with $500m facility spend

Pfizer logoContinues to build on its growing gene therapy business

Business in the USAHealth coverage across state lines

Despite a total lack of legislative wins, the new administration has made its presence felt at home and abroad

  • Ho_Ung_KimStanding out in a crowd

    Celltrion Healthcare’s Ho-Ung Kim on pricing, market access and regulatory challenges for successfully developing biosimilars

  • HeadsThe diseased organisation

    Like humans, organisations can be afflicted by genetic disorders that hinder performance and threaten survival but these can be understood and cured

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics